You are viewing: GCC Countries Endoscopic Submucosal Dissection/ESD Market analysis

The GCC Countries Endoscopic Submucosal Dissection/ESD Market was valued at $4.7 Million in 2025 and projected to reach to $7.3 Million by 2030, representing a compound annual growth rate of 9.1%. The ESD market in GCC Countries is poised for sustained growth through 2030, driven by increasing prevalence of gastrointestinal malignancies and growing awareness of endoscopic treatment benefits among healthcare providers and patients.

GCC Countries Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

GCC Countries Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • GCC Countries are witnessing accelerated adoption of minimally invasive endoscopic procedures, supported by substantial healthcare investments and state-of-the-art medical facilities across the region.
  • The market growth in GCC Countries reflects increasing prevalence of gastrointestinal malignancies and rising demand for advanced diagnostic and therapeutic interventions. GCC Countries benefit from high healthcare spending, well-trained medical professionals, and strong regulatory frameworks that facilitate rapid technology adoption.
  • The forecast period through 2030 indicates sustained momentum in GCC Countries, driven by growing patient awareness, expanding endoscopy centers, and integration of cutting-edge ESD equipment.
  • GCC Countries' strategic positioning as a regional healthcare hub further accelerates market penetration and clinical adoption of ESD procedures..

Key Market Statistics

  • CAGR (2025-2030) 9.1% CAGR
  • Market Size, 2025 ~USD 4.7 Million
  • Forecast, 2030 ~USD 7.3 Million
  • Country GCC Countries

GCC Countries Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation Growth :

GCC Countries ESD market valued at USD 4.7 million in 2025, expanding to USD 7.3 million by 2030, representing a robust 9.1% CAGR, outpacing the global average of 8.4%.

Healthcare Infrastructure Investment :

GCC nations are investing heavily in state-of-the-art medical facilities and advanced endoscopic technologies, positioning the region as a hub for minimally invasive procedures and attracting international medical device manufacturers.

Minimally Invasive Procedure Adoption :

Accelerated adoption of ESD procedures across GCC Countries driven by rising patient preference for less invasive treatments, shorter recovery times, and improved clinical outcomes in gastrointestinal cancer management.

Regional Medical Excellence :

GCC Countries' commitment to healthcare quality, coupled with high disposable incomes and comprehensive insurance coverage, creates favorable conditions for premium ESD device adoption and procedural volume growth.

GCC Countries Endoscopic Submucosal Dissection/ESD Market Dynamics

  • Government healthcare initiatives and private sector investments in medical technology infrastructure are accelerating the adoption of advanced ESD systems across major hospitals and specialized endoscopy centers throughout the region. Key growth catalysts include rising medical tourism, expanding training programs for endoscopic specialists, and strategic partnerships between regional healthcare providers and global ESD device manufacturers.
  • The region's affluent patient demographics and comprehensive healthcare coverage systems support higher adoption rates of premium ESD technologies, positioning GCC Countries as a significant growth market within the Middle East healthcare landscape..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • GCC Countries ESD market valued at USD 4.7 million in 2025, expanding to USD 7.3 million by 2030 at 9.1% CAGR
    • GCC Countries' advanced healthcare infrastructure and high medical spending drive rapid adoption of minimally invasive endoscopic technologies
    • Rising gastrointestinal cancer prevalence in GCC Countries creates sustained demand for ESD procedures and specialized equipment
    • GCC Countries' position as a regional medical hub attracts international investment and accelerates clinical innovation in endoscopy

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    GCC Countries Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ESD device and equipment manufacturers need GCC-specific market data to identify growth opportunities, assess regional demand, and develop localized product strategies for this high-value healthcare market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed GCC market analysis to evaluate investment opportunities in endoscopy centers, medical technology companies, and healthcare infrastructure projects in the region.
    • Hospital & Clinic Operators : Healthcare facility administrators need market insights to justify ESD program investments, benchmark against regional peers, and plan endoscopy department expansion and technology upgrades.
    • Distributors & Importers : Medical device distributors operating in GCC Countries require market forecasts and competitive intelligence to optimize inventory, negotiate supplier agreements, and identify emerging opportunities.
    • Healthcare Consultants & Advisors : Consulting firms advising healthcare organizations and medical technology companies need GCC-specific market data to provide credible strategic recommendations and support client decision-making.

    Key Companies in the GCC Countries Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to GCC Countries with detailed 2025-2030 projections, enabling accurate business planning and investment decisions tailored to this high-growth regional market.
    • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning within GCC Countries' ESD sector to identify partnership opportunities, market entry strategies, and differentiation approaches.
    • Healthcare Infrastructure Insights : Access detailed analysis of GCC healthcare investments, facility capabilities, and adoption patterns to align product offerings with regional medical standards and procurement preferences.
    • Growth Driver Analysis : Identify specific factors accelerating ESD adoption in GCC Countries including regulatory environment, reimbursement policies, clinical practice trends, and patient demographics to optimize market penetration strategies.
    • Strategic Market Entry Planning : Leverage GCC-specific market intelligence to develop targeted go-to-market strategies, distribution partnerships, and localized marketing approaches for successful regional expansion.

    Frequently asked questions

    What is the current market size of ESD in GCC Countries?

    The Endoscopic Submucosal Dissection market in GCC Countries was valued at USD 4.7 million in 2025.

    What is the projected market size for ESD in GCC Countries by 2030?

    GCC Countries' ESD market is forecasted to reach USD 7.3 million by 2030, representing significant growth over the forecast period.

    What is the CAGR for the ESD market in GCC Countries?

    The Endoscopic Submucosal Dissection market in GCC Countries is expected to grow at a compound annual growth rate of 9.1% from 2025 to 2030.

    What factors are driving ESD market growth in GCC Countries?

    GCC Countries' market growth is driven by advanced healthcare infrastructure, high medical spending, increasing gastrointestinal cancer prevalence, and expanding endoscopy centers.

    Why is GCC Countries an important market for ESD technology?

    GCC Countries serves as a regional healthcare hub with strong regulatory frameworks, well-trained medical professionals, and substantial investment in cutting-edge medical technologies, making it a strategic market for ESD adoption.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status